CBG(SZ:000009)2020-04-28 16:00Dividend Distribution - The company plans to distribute a cash dividend of 0.20 RMB per 10 shares to all shareholders, based on a total of 2,579,213,965 shares[3]. - The company plans to distribute a cash dividend of 0.20 yuan per 10 shares, totaling 51,584,279.30 yuan for the year 2019, which represents 17.13% of the net profit attributable to ordinary shareholders[79]. - The total number of shares for the dividend distribution base in 2019 is 2,579,213,965 shares[82]. - The company has maintained a consistent cash dividend policy over the past three years, with cash dividends of 42,986,899.42 yuan in 2017 and 42,986,899.42 yuan in 2018, representing 32.27% and 20.11% of net profit respectively[81]. Business Operations and Strategy - The company has undergone changes in its main business operations since its listing in June 1991, including a shift towards high-tech industries such as new materials and renewable energy[11]. - The company is focused on expanding its operations in high-tech industries, including modern biomedicine and renewable energy projects[11]. - The company is focused on developing a high-tech industrial group centered on new materials, with ongoing efforts in upgrading operations and risk prevention[19]. - The company aims to build a high-tech industrial group focused on new materials, capitalizing on the rapid development of the new materials industry driven by national policies[73]. - The biopharmaceutical sector will continue to innovate and upgrade business models in response to new opportunities and challenges in the healthcare market[74]. - The real estate sector will focus on sales, inventory reduction, and cash recovery to improve operational efficiency and profitability[74]. - The company plans to implement a strategy of "securitization, light assets, low debt, and high efficiency" to ensure stable and sustainable development in 2020[75]. Financial Performance - The company's operating revenue for 2019 was ¥11,948,727,206.58, representing a year-on-year increase of 1.99% compared to ¥11,715,547,130.35 in 2018[13]. - The net profit attributable to shareholders for 2019 was ¥301,136,296.48, a significant increase of 40.86% from ¥213,780,584.63 in 2018[14]. - The basic earnings per share for 2019 was ¥0.1168, up 40.89% from ¥0.0829 in 2018[14]. - The weighted average return on equity for 2019 was 5.54%, an increase from 4.18% in 2018[14]. - The total profit reached 563 million yuan, representing a year-on-year increase of 42.93%[30]. - The company achieved a net profit of CNY 301,136,296.48 for the year 2019, with a net profit attributable to the parent company of CNY 178,079,602.89[83]. Shareholder Information - The company reported that its major shareholders include Shenzhen Fu'an Holdings Co., Ltd. and Shenzhen Bao'an District Investment Management Co., Ltd., holding 8.34% and 6.95% respectively after the equity division reform in May 2008[11]. - The largest shareholder, Shenzhen Fu'an Holdings Co., Ltd., holds 11.91% of the shares, amounting to 307,216,678 shares, with an increase of 51,202,780 shares during the reporting period[145]. - The second-largest shareholder, Shenzhen Baoan District Investment Management Co., Ltd., holds 5.57% of the shares, totaling 143,744,852 shares, with an increase of 23,957,475 shares[145]. - The company has no controlling shareholder or actual controller, with the largest shareholders holding more than 5% being Shenzhen Fu'an Holdings Co., Ltd. and Shenzhen Bao'an District Investment Management Group Co., Ltd.[148]. Legal Proceedings - The company has provided guarantees for loans totaling RMB 149.09 million and has initiated legal proceedings to recover these amounts, but has not yet succeeded in recovering the debts due to the defendants' inability to repay[102]. - The company is pursuing bankruptcy proceedings against three defendants involved in the loan guarantees, with one case being rejected by the Shenzhen Intermediate People's Court[102]. - The company has initiated a lawsuit against Hu Zhiqiang for a stock repurchase agreement, claiming a total of RMB 19.20 million, which includes the repurchase amount and penalties[103]. - The company is currently involved in multiple legal disputes, with ongoing bankruptcy proceedings affecting related parties[105]. - The company is actively pursuing its legal rights and claims in various ongoing litigation matters[105]. Risk Management - The company has detailed risk factors and corresponding measures in its report, highlighting potential challenges for future development[3]. - The company is addressing risks in the high-tech industry by implementing lean management and enhancing collaboration with customers to meet market demands[76]. - The real estate sector faces risks related to policy and market fluctuations, with a focus on inventory management and sales acceleration to improve cash flow[78]. Research and Development - The company is actively investing in research and development to innovate and develop new products, aiming to improve core competitiveness[76]. - Research and development expenses increased by 8.07% to ¥400,788,674.37 in 2019, compared to ¥370,862,736.96 in 2018[50]. - The company’s R&D investment reached ¥409,051,700.70 in 2019, up 8.73% from ¥376,191,746.25 in 2018, with R&D investment accounting for 3.42% of operating revenue[52]. Environmental Responsibility - The company is committed to fulfilling its social responsibilities regarding environmental protection and pollution prevention[131]. - The wastewater treatment facilities of Beiterui New Materials Group operated normally with no exceedance of discharge standards[131]. - Yibin Jinshi New Materials Technology implemented multiple measures for air pollution control, ensuring no exceedance of emission standards[131]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[129]. Corporate Governance - The company has established a robust corporate governance structure, complying with relevant laws and regulations, and ensuring independent operation without major shareholder interference[175]. - The audit committee confirmed that the audited financial statements for 2018 align with the company's actual operating conditions, ensuring the completeness and reliability of the financial information[182]. - The company has not identified any significant internal control deficiencies during the reporting period[189]. - The company is committed to maintaining transparency and accountability in its financial reporting and governance practices[160].